All posts in Chinese regulators approve Alzheimer’s drug

Last week, Chinese regulators granted conditional approval for a new Alzheimer’s drug. The seaweed-derived compound purportedly improves cognitive function by altering the gut bacteria of Alzheimer’s patients. The drug called